Biotechnology Stocks I Performance Guide: Amylyx Pharmaceuticals, Inc. (AMLX)
AMLX has no dividends
Table and Chart of AMLX Performance
See what a $1,000 investment in AMLX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| AMLX Returns | |
|---|---|
| Start Date | Feb-28-2022 |
| Start Price | $32.90 |
| End Date | Dec-01-2023 |
| End Price | $14.22 |
| # Prices | 23 |
| Min Date | May-31-2022 |
| Min Price | $8.89 |
| Max Date | Jan-31-2023 |
| Max Price | $39.19 |
| Total Return | -56.78% |
| Annualized Return | -35.44% |
| Current Value of $1,000 Purchase | $432 |
| Number Returns | 253 |
| Average Return | 23.65% |
| Number Profitable Returns | 106 |
| Percent Profitable Returns | 41.90% |
| Number Unprofitable Returns | 147 |
| Percent Unprofitable Returns | 58.10% |
| Profitable to Unprofitable Returns Ratio | 0.72 |
| AMLX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $960,103,000 | Price to Sales | 3.26 |
| Earnings per Share | $0.0100 |
| PE Ratio | 1422 |
| PE to Growth Ratio | None |
| Price to Book | 2.295 |
| PRICE DATA | |
| 52 Week High | $41.93 |
| 52 Week Low | $11.82 |
| Analyst Target Price | $39.4 |
| 50-Day Moving Average | $16.06 |
| 200-Day Moving Average | $23.55 |
| FINANCIAL DATA | |
| Revenue per Share | $4.41 |
| Revenue | $294,222,000 |
| Profit Margin | 0.62% |
| Return on Equity | 0.0065% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
AMLX Compare Returns with S&P 500
AMLX Trendline Chart